Abstract:In this study, in vitro cytotoxicity of nickel zinc (NiZn) ferrite nanoparticles against human colon cancer HT29, breast cancer MCF7, and liver cancer HepG2 cells was examined. The morphology, homogeneity, and elemental composition of NiZn ferrite nanoparticles were investigated by scanning electron microscopy, transmission electron microscopy, and energy dispersive X-ray spectroscopy, respectively. The exposure of cancer cells to NiZn ferrite nanoparticles (15.6-1,000 µg/mL; 72 hours) has resulted in a dose-dependent inhibition of cell growth determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The quantification of caspase-3 and -9 activities and DNA fragmentation to assess the cell death pathway of the treated cells showed that both were s timulated when exposed to NiZn ferrite nanoparticles. Light microscopy examination of the cells exposed to NiZn ferrite nanoparticles demonstrated significant changes in cellular morphology. The HepG2 cells were most prone to apoptosis among the three cells lines examined, as the result of treatment with NiZn nanoparticles. In conclusion, NiZn ferrite nanoparticles are suggested to have potential cytotoxicity against cancer cells.
A facile thermal-treatment route was successfully used to synthesize ZnO nanosheets. Morphological, structural, and optical properties of obtained nanoparticles at different calcination temperatures were studied using various techniques. The FTIR, XRD, EDX, SEM and TEM images confirmed the formation of ZnO nanosheets through calcination in the temperature between 500 to 650°C. The SEM images showed a morphological structure of ZnO nanosheets, which inclined to crumble at higher calcination temperatures. The XRD and FTIR spectra revealed that the samples were amorphous at 30°C but transformed into a crystalline structure during calcination process. The average particle size and degree of crystallinity increased with increasing calcination temperature. The estimated average particle sizes from TEM images were about 23 and 38 nm for the lowest and highest calcination temperature i.e. 500 and 650°C, respectively. The optical properties were determined by UV–Vis reflection spectrophotometer and showed a decrease in the band gap with increasing calcination temperature.
In this research, a thermal treatment method was used to synthesize cadmium oxide nanoparticles. The metal precursor, cadmium nitrate and a capping agent were dissolved in deionized water, which later was dried and crushed into powder. The powder underwent calcination treatment of 500, 550, 600, and 650 °C to crystallize the nanoparticles and to remove organic compounds. The structural studies of CdO nanoparticles have been carried out using EDAX, FTIR, XRD, SEM and TEM. The FTIR and XRD spectra showed that the crystalline structure formation of metal oxide nanoparticles has only occurred after been exposed to calcination. The optical properties which were determined using a UV-vis spectrophotometer showed a decrease in the band gap with increasing calcination temperature. These results prove that the thermal treatment method is a simple technique that can produce pure metal oxide nanoparticles with no other chemicals added.
The long-term objective of the present study was to determine the ability of NiZn ferrite nanoparticles to kill cancer cells. NiZn ferrite nanoparticle suspensions were found to have an average hydrodynamic diameter, polydispersity index, and zeta potential of 254.2 ± 29.8 nm, 0.524 ± 0.013, and −60 ± 14 mV, respectively. We showed that NiZn ferrite nanoparticles had selective toxicity towards MCF-7, HepG2, and HT29 cells, with a lesser effect on normal MCF 10A cells. The quantity of
Bcl-2
,
Bax
,
p53
, and
cytochrome C
in the cell lines mentioned above was determined by colorimetric methods in order to clarify the mechanism of action of NiZn ferrite nanoparticles in the killing of cancer cells. Our results indicate that NiZn ferrite nanoparticles promote apoptosis in cancer cells via caspase-3 and caspase-9, downregulation of
Bcl-2
, and upregulation of
Bax
and
p53
, with
cytochrome C
translocation. There was a concomitant collapse of the mitochondrial membrane potential in these cancer cells when treated with NiZn ferrite nanoparticles. This study shows that NiZn ferrite nanoparticles induce glutathione depletion in cancer cells, which results in increased production of reactive oxygen species and eventually, death of cancer cells.
Abstract:A water-based solution of polyvinylpyrrolidone (PVP) at various concentrations and zinc nitrates were used in conjunction with calcination to produce zinc oxide semiconductor nanoparticles. The extent to which the zinc oxide semiconductor nanoparticles had become crystallized was measured using X-ray diffraction (XRD), whilst morphological characteristics were determined using scanning electron microscopy (SEM). Transmission electron microscopy (TEM) supported by XRD results were used to evaluate the average particle size. Fourier transform infrared spectroscopy (FT-IR) was then carried out in order to identify the composition phase, since this suggested that the samples contained metal oxide bands and that all organic compounds had been effectively removed after calcination. A UV-VIS spectrophotometer was used to determine the energy band gap and illustrate optical features. Additionally, photoluminescence (PL) spectra revealed that the intensity of photoluminescence decreased with a decrease in particle size. The obtained results have mainly been inclusive for uses by several semiconductor applications in different fields, such as environmental applications and studies, since an absorption process for energy wavelengths could efficiently occur.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.